Enalapril vs Tildrakizumab

## Enalapril vs Tildrakizumab: Overview

This comparison examines the pharmacological differences between **Enalapril** and **Tildrakizumab**.

## Mechanism of Action

**Enalapril**: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

## Pharmacokinetics

**Half-life**: Enalapril — 11 hours; Tildrakizumab — N/A.

## Chemical Properties

**Molecular Formula**: Enalapril — C20H28N2O5; Tildrakizumab — N/A.

**Molecular Weight**: Enalapril — 376.4470 g/mol; Tildrakizumab — N/A.

**Type**: Enalapril — Small molecule; Tildrakizumab — Antibody.